112420-09-4 ((b-L-Gulopyranose,1,6-anhydro-2,3-O-(phenylmethylene)-, (S)- (9CI))

快速询单

结构式：

b-L-Gulopyranose,1,6-anhydro-2,3-O-(phenylmethylene)-, (S)- (9CI)MOL文件

CAS号：

112420-09-4

英文名称：

b-L-Gulopyranose,1,6-anhydro-2,3-O-(phenylmethylene)-, (S)- (9CI)

分子式：

C₁₁H₉FN₂O₃

分子量：

236.199166059494

b-L-Gulopyranose,1,6-anhydro-2,3-O-(phenylmethylene)-, (S)- (9CI)(112420-09-4)名称与标识符

名称

英文别名：

b-L-Gulopyranose,1,6-anhydro-2,3-O-(phenylmethylene)-, (S)- (9CI);.beta.-L-Gulopyranose, 1,6-anhydro-2,3-O-(phenylmethylene)-, (S)-;β-L-Gulopyranose, 1,6-anhydro-2,3-O-(phenylmethylene)-, (S)- (9CI);

标识符

InChIKey：

LXANPKRCLVQAOG-NSHDSACASA-N

Inchi：

1S/C11H9FN2O3/c12-6-1-2-8-7(5-6)11(3-4-17-8)9(15)13-10(16)14-11/h1-2,5H,3-4H2,(H2,13,14,15,16)/t11-/m0/s1

SMILES：

C1OC2=C(C=C(F)C=C2)[C@@]2(NC(=O)NC2=O)C1

b-L-Gulopyranose,1,6-anhydro-2,3-O-(phenylmethylene)-, (S)- (9CI)(112420-09-4)相关文献

1. Identification of novel pyrazole–rhodanine hybrid scaffolds as potent inhibitors of aldose reductase: design, synthesis, biological evaluation and molecular docking analysis
Hina Andleeb,Yildiz Tehseen,Syed Jawad Ali Shah,Imtiaz Khan,Jamshed Iqbal,Shahid Hameed RSC Adv. 2016 6 77688
2. Exploring synthetic and therapeutic prospects of new thiazoline derivatives as aldose reductase (ALR2) inhibitors
Muhammad Tariq Shehzad,Aqeel Imran,Abdul Hameed,Mariya al Rashida,Marium Bibi,Maliha Uroos,Asnuzilawati Asari,Shafia Iftikhar,Habsah Mohamad,Muhammad Nawaz Tahir,Zahid Shafiq,Jamshed Iqbal RSC Adv. 2021 11 17259
3. Design, synthesis and molecular modelling of novel methyl[4-oxo-2-(aroylimino)-3-(substituted phenyl)thiazolidin-5-ylidene]acetates as potent and selective aldose reductase inhibitors
Sher Ali,Aamer Saeed,Naeem Abbas,Mohammad Shahid,Michael Bolte,Jamshed Iqbal Med. Chem. Commun. 2012 3 1428
4. Benzothiazolyl substituted iminothiazolidinones and benzamido-oxothiazolidines as potent and partly selective aldose reductase inhibitors
Aamer Saeed,Yildiz Tehseen,Hummera Rafique,Norbert Furtmann,Jürgen Bajorath,Ulrich Fl?rke,Jamshed Iqbal Med. Chem. Commun. 2014 5 1371
5. Heterocyclic compounds as a magic bullet for diabetes mellitus: a review
Umme Farwa,Muhammad Asam Raza RSC Adv. 2022 12 22951
6. Formation of optically active chromanes by catalytic asymmetric tandem oxa-Michael addition–Friedel–Crafts alkylation reactions
Hester L. van Lingen,Wei Zhuang,Tore Hansen,Floris P. J. T. Rutjes,Karl Anker J?rgensen Org. Biomol. Chem. 2003 1 1953
7. Naturally occurring organoiodines
Lishu Wang,Xuefeng Zhou,Mangaladoss Fredimoses,Shengrong Liao,Yonghong Liu RSC Adv. 2014 4 57350
8. The chemistry of 2-hydroxy-β-nitrostyrenes: versatile intermediates in synthetic organic chemistry
Azim Ziyaei Halimehjani,Zahra Ghaffari Org. Biomol. Chem. 2023 21 2653
9. Employment of α-nitroketones in organic synthesis
Chandan Gharui,Subhas chandra Pan Org. Biomol. Chem. 2019 17 5190
10. Oxazolidinones as versatile scaffolds in medicinal chemistry
Guilherme Felipe Santos Fernandes,Cauê Benito Scarim,Seong-Heun Kim,Jingyue Wu,Daniele Castagnolo RSC Med. Chem. 2023 14 823

112420-09-4 ((b-L-Gulopyranose,1,6-anhydro-2,3-O-(phenylmethylene)-, (S)- (9CI))

b-L-Gulopyranose,1,6-anhydro-2,3-O-(phenylmethylene)-, (S)- (9CI)(112420-09-4)名称与标识符

名称

标识符

b-L-Gulopyranose,1,6-anhydro-2,3-O-(phenylmethylene)-, (S)- (9CI)(112420-09-4)相关文献

目录